There are a number of people in my domain that I have great appreciation for and that I enjoy working with. So, an opportunity to co-author on rules for licensing data with Sean Ekins and John Wilbanks was an opportunity too good to miss. There are a lot of opinions, rants and views on data licensing floating around the internet, discussed at conferences and over beverages. Meanwhile we have opinions too and have shared them through this perspective on PLoS Computational Biology through this paper: “Why Open Drug Discovery Needs Four Simple Rules for Licensing Data and Models”
Search ChemConnector
My ResearchGate Profile
Feedburner
-
Recent Posts on ChemConnector
- COVID-19 Karaoke Part 2 by “Tony’s Midnight Humours”
- Screw You COVID-19 – My Karaoke Dedication
- QSAR 2020: From QSAR to New Approach Methodologies (NAMs)
- Chemical identification of unknowns in high resolution mass spectrometry using the EPA’s CompTox Chemicals Dashboard
- Converting Dates to CAS Registry Numbers in Excel